🇺🇸 FDA
Patent

US 11446397

Gene therapy vectors for treating heart disease

granted A61KA61K38/00A61K48/005

Quick answer

US patent 11446397 (Gene therapy vectors for treating heart disease) held by Tenaya Therapeutics, Inc. expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Tenaya Therapeutics, Inc.
Grant date
Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/00, A61K48/005, A61K48/0058, A61P